Table 2 Details of pneumothorax events during pazopanib treatment
Patient characteristics | Clinical status at the occurrence of pneumothorax | |||||
|---|---|---|---|---|---|---|
No. | Age | Pathological diagnosis | Treatment day | Grade | Bilateral | Chest drainage |
1 | 60’s | Undifferentiated sarcoma, NOS | 115 | 1 | No | No |
2 | 40’s | Carcinosarcoma | 12 | 3 | No | Yes |
3 | 20’s | Undifferentiated sarcoma, NOS | 6 | 3 | No | Yes |
25 | 3 | No | Yes | |||
61 | 3 | Yes | Yes | |||
129 | 2 | No | Yes | |||
144 | 3 | No | Yes | |||
4 | 20’s | Synovial sarcoma | 55 | 3 | No | Yes |
95 | 3 | Yes | Yes | |||
5 | 50’s | Synovial sarcoma | 145 | 1 | No | No |
174 | 2 | No | No | |||
282 | 1 | No | No | |||
6 | 30’s | Synovial sarcoma | 311 | 2 | No | No |